Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Particle Characterization and Rheology Systems

By Drug Discovery Trends Editor | January 29, 2009

Malvern's KinexusMalvern will feature a new range of particle characterization and rheology systems, and a new Viscotek chromatography product, at Pittcon 2009. Malvern’s Kinexus rotational rheometer, Zetasizer APS and Zetasizer µV particle characterization systems, and a new application for the Morphologi G3, will be on display. The launch of a new detector for the Viscotek TDAmax gel permeation chromatography system also celebrates the first anniversary of Malvern’s acquisition of the company. 

Malvern’s Kinexus is a rotational rheometer platform. It incorporates technological innovations in rheometer design, from sample preparation and loading, through measurement set-up and operation, to data analysis and reporting. Adaptive intelligence allows Kinexus to actively guide users at every stage.

The Zetasizer APS, a dynamic light scattering system, automates size measurements of Malvern's Zetasizer APSsamples in 96- or 384-well microplates. Designed for protein specialists, the system is fully automated, requiring users to insert the plate and press start. It allows for investigation of a protein’s condition at different stages of the purification process, and at later stages of formulation under a range of environmental conditions.

Malvern's Zetasizer µVThe Zetasizer µV is an advanced light scattering system intended for the characterization of proteins and other biomolecules. Requiring just two microlitres of sample, it enables measurement of as little as 40 nanograms of BSA (bovine serum albumin) for example. This system supports improved understanding and management of a wide range of biomolecule applications. Malvern's Morphologi G3 

A new capability for the Morphologi G3 particle characterization system enables the fully automated detection, enumeration, and size classification of foreign particulate matter collected on a filter. Traditionally this has been the preserve of manual light microscopy. Now the Morphologi G3 brings fully automated image analysis to accelerate characterization and remove any operator subjectivity.

Visit Malvern at booth #2027 at Pittcon 2009.

www.malvern.com


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50